context stringlengths 21 33.9k | category stringclasses 2 values | entity stringlengths 1 12 | entity_type stringclasses 5 values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
All of the Company’s employees are eligible for defined contribution pension plans. Contributions are primarily based upon a percentage of eligible compensation. The Company contributed $ 12.0 million to its defined contribution pension plans in 2024 (2023 - $ 9.5 million, 2022 - $ 6.7 million). | text | 9.5 | monetaryItemType | text: <entity> 9.5 </entity> <entity type> monetaryItemType </entity type> <context> All of the Company’s employees are eligible for defined contribution pension plans. Contributions are primarily based upon a percentage of eligible compensation. The Company contributed $ 12.0 million to its defined contribution pension plans in 2024 (2023 - $ 9.5 million, 2022 - $ 6.7 million). </context> | us-gaap:DefinedContributionPlanCostRecognized |
All of the Company’s employees are eligible for defined contribution pension plans. Contributions are primarily based upon a percentage of eligible compensation. The Company contributed $ 12.0 million to its defined contribution pension plans in 2024 (2023 - $ 9.5 million, 2022 - $ 6.7 million). | text | 6.7 | monetaryItemType | text: <entity> 6.7 </entity> <entity type> monetaryItemType </entity type> <context> All of the Company’s employees are eligible for defined contribution pension plans. Contributions are primarily based upon a percentage of eligible compensation. The Company contributed $ 12.0 million to its defined contribution pension plans in 2024 (2023 - $ 9.5 million, 2022 - $ 6.7 million). </context> | us-gaap:DefinedContributionPlanCostRecognized |
had an ordinary dividend capacity of $ 125.5 million which can be paid in 2025. Payment of ordinary dividends by Renaissance Reinsurance U.S. requires notice to the MIA. Declaration of an extraordinary dividend, which must be paid out of earned surplus, generally requires thirty days’ prior notice to and approval or non-disapproval of the MIA. An extraordinary dividend includes any dividend whose fair market value together with that of other dividends or distributions made within the preceding twelve months exceeds the lesser of (1) ten percent of the insurer’s surplus as regards policyholders as of December 31 of the preceding year or (2) the insurer’s net investment income, excluding realized capital gains (as determined under statutory accounting principles), for the twelve month period ending December 31 of the preceding year and pro rata distributions of any class of the insurer’s own securities, plus any amounts of net investment income (subject to the foregoing exclusions), in the three calendar years prior to the preceding year which have not been distributed. | text | 125.5 | monetaryItemType | text: <entity> 125.5 </entity> <entity type> monetaryItemType </entity type> <context> had an ordinary dividend capacity of $ 125.5 million which can be paid in 2025. Payment of ordinary dividends by Renaissance Reinsurance U.S. requires notice to the MIA. Declaration of an extraordinary dividend, which must be paid out of earned surplus, generally requires thirty days’ prior notice to and approval or non-disapproval of the MIA. An extraordinary dividend includes any dividend whose fair market value together with that of other dividends or distributions made within the preceding twelve months exceeds the lesser of (1) ten percent of the insurer’s surplus as regards policyholders as of December 31 of the preceding year or (2) the insurer’s net investment income, excluding realized capital gains (as determined under statutory accounting principles), for the twelve month period ending December 31 of the preceding year and pro rata distributions of any class of the insurer’s own securities, plus any amounts of net investment income (subject to the foregoing exclusions), in the three calendar years prior to the preceding year which have not been distributed. </context> | us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval |
The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). | text | 7.1 | monetaryItemType | text: <entity> 7.1 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). | text | 5.9 | monetaryItemType | text: <entity> 5.9 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). | text | 2.7 | monetaryItemType | text: <entity> 2.7 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of interest rate futures is determined using exchange traded prices. At December 31, 2024, the Company had $ 7.1 billion of notional long positions and $ 3.1 billion of notional short positions of primarily U.S. treasury and non-US government bond futures contracts (2023 – $ 5.9 billion and $ 2.7 billion, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). | text | 508.8 | monetaryItemType | text: <entity> 508.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). | text | 805.2 | monetaryItemType | text: <entity> 805.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). | text | 496.4 | monetaryItemType | text: <entity> 496.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s foreign currency policy with regard to its underwriting operations is generally to enter into foreign currency forward and option contracts for notional values that approximate the foreign currency liabilities, including claims and claim expense reserves and reinsurance balances payable, net of any cash, investments and receivables held in the respective foreign currency. The Company’s use of foreign currency forward and option contracts is intended to minimize the effect of fluctuating foreign currencies on the value of non-U.S. dollar denominated assets and liabilities associated with its underwriting operations. The Company may determine not to match a portion of its projected underwriting related assets or liabilities with underlying foreign currency exposure with investments in the same currencies, which would increase its exposure to foreign currency fluctuations and potentially increase the impact and volatility of foreign exchange gains and losses on its results of operations. The fair value of the Company’s underwriting operations related foreign currency contracts is determined using indicative pricing obtained from counterparties or broker quotes. At December 31, 2024, the Company had outstanding underwriting related foreign currency contracts of $ 1.0 billion in notional long positions and $ 508.8 million in notional short positions, denominated in U.S. dollars (2023 - $ 805.2 million and $ 496.4 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). | text | 345.0 | monetaryItemType | text: <entity> 345.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). | text | 107.0 | monetaryItemType | text: <entity> 107.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). | text | 420.7 | monetaryItemType | text: <entity> 420.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). | text | 130.0 | monetaryItemType | text: <entity> 130.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s investment operations are exposed to currency fluctuations through its investments in non-U.S. dollar fixed maturity investments, short term investments and other investments. From time to time, the Company may employ foreign currency forward contracts in its investment portfolio to either assume foreign currency risk or to economically hedge its exposure to currency fluctuations from these investments. The fair value of the Company’s investment portfolio related foreign currency forward contracts is determined using an interpolated rate based on closing forward market rates. At December 31, 2024, the Company had outstanding investment portfolio related foreign currency contracts of $ 345.0 million in notional long positions and $ 107.0 million in notional short positions, denominated in U.S. dollars (2023 - $ 420.7 million and $ 130.0 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of the Company’s credit default swaps is determined using industry valuation models, broker bid indications or internal pricing valuation techniques. The fair value of these credit default swaps can change based on a variety of factors including changes in credit spreads, default rates and recovery rates, the correlation of credit risk between the referenced credit and the counterparty, and market rate inputs such as interest rates. At December 31, 2024, the Company had outstanding credit default swaps of $ 1.4 billion in notional positions to protect the investment portfolio against increasing credit risk and $ Nil in notional positions to assume credit risk, denominated in U.S. dollars (2023 - $ 1.5 billion and $ 22.1 million, respectively). | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s credit default swaps is determined using industry valuation models, broker bid indications or internal pricing valuation techniques. The fair value of these credit default swaps can change based on a variety of factors including changes in credit spreads, default rates and recovery rates, the correlation of credit risk between the referenced credit and the counterparty, and market rate inputs such as interest rates. At December 31, 2024, the Company had outstanding credit default swaps of $ 1.4 billion in notional positions to protect the investment portfolio against increasing credit risk and $ Nil in notional positions to assume credit risk, denominated in U.S. dollars (2023 - $ 1.5 billion and $ 22.1 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of the Company’s credit default swaps is determined using industry valuation models, broker bid indications or internal pricing valuation techniques. The fair value of these credit default swaps can change based on a variety of factors including changes in credit spreads, default rates and recovery rates, the correlation of credit risk between the referenced credit and the counterparty, and market rate inputs such as interest rates. At December 31, 2024, the Company had outstanding credit default swaps of $ 1.4 billion in notional positions to protect the investment portfolio against increasing credit risk and $ Nil in notional positions to assume credit risk, denominated in U.S. dollars (2023 - $ 1.5 billion and $ 22.1 million, respectively). | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s credit default swaps is determined using industry valuation models, broker bid indications or internal pricing valuation techniques. The fair value of these credit default swaps can change based on a variety of factors including changes in credit spreads, default rates and recovery rates, the correlation of credit risk between the referenced credit and the counterparty, and market rate inputs such as interest rates. At December 31, 2024, the Company had outstanding credit default swaps of $ 1.4 billion in notional positions to protect the investment portfolio against increasing credit risk and $ Nil in notional positions to assume credit risk, denominated in U.S. dollars (2023 - $ 1.5 billion and $ 22.1 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of the Company’s credit default swaps is determined using industry valuation models, broker bid indications or internal pricing valuation techniques. The fair value of these credit default swaps can change based on a variety of factors including changes in credit spreads, default rates and recovery rates, the correlation of credit risk between the referenced credit and the counterparty, and market rate inputs such as interest rates. At December 31, 2024, the Company had outstanding credit default swaps of $ 1.4 billion in notional positions to protect the investment portfolio against increasing credit risk and $ Nil in notional positions to assume credit risk, denominated in U.S. dollars (2023 - $ 1.5 billion and $ 22.1 million, respectively). | text | 22.1 | monetaryItemType | text: <entity> 22.1 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s credit default swaps is determined using industry valuation models, broker bid indications or internal pricing valuation techniques. The fair value of these credit default swaps can change based on a variety of factors including changes in credit spreads, default rates and recovery rates, the correlation of credit risk between the referenced credit and the counterparty, and market rate inputs such as interest rates. At December 31, 2024, the Company had outstanding credit default swaps of $ 1.4 billion in notional positions to protect the investment portfolio against increasing credit risk and $ Nil in notional positions to assume credit risk, denominated in U.S. dollars (2023 - $ 1.5 billion and $ 22.1 million, respectively). </context> | us-gaap:DerivativeNotionalAmount |
From time to time, the Company uses equity derivatives in its investment portfolio to either assume equity risk or hedge its equity exposure. The fair value of the Company’s equity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 437.2 million of notional long positions of equity futures (2023 - $ Nil notional long positions). | text | 437.2 | monetaryItemType | text: <entity> 437.2 </entity> <entity type> monetaryItemType </entity type> <context> From time to time, the Company uses equity derivatives in its investment portfolio to either assume equity risk or hedge its equity exposure. The fair value of the Company’s equity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 437.2 million of notional long positions of equity futures (2023 - $ Nil notional long positions). </context> | us-gaap:DerivativeNotionalAmount |
From time to time, the Company uses equity derivatives in its investment portfolio to either assume equity risk or hedge its equity exposure. The fair value of the Company’s equity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 437.2 million of notional long positions of equity futures (2023 - $ Nil notional long positions). | text | Nil | monetaryItemType | text: <entity> Nil </entity> <entity type> monetaryItemType </entity type> <context> From time to time, the Company uses equity derivatives in its investment portfolio to either assume equity risk or hedge its equity exposure. The fair value of the Company’s equity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 437.2 million of notional long positions of equity futures (2023 - $ Nil notional long positions). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of the Company’s commodity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had a $ 684.3 million of notional long positions of commodity futures, denominated in U.S. dollars (2023 - $ 255.2 million of notional long positions). | text | 684.3 | monetaryItemType | text: <entity> 684.3 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s commodity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had a $ 684.3 million of notional long positions of commodity futures, denominated in U.S. dollars (2023 - $ 255.2 million of notional long positions). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of the Company’s commodity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had a $ 684.3 million of notional long positions of commodity futures, denominated in U.S. dollars (2023 - $ 255.2 million of notional long positions). | text | 255.2 | monetaryItemType | text: <entity> 255.2 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of the Company’s commodity futures is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had a $ 684.3 million of notional long positions of commodity futures, denominated in U.S. dollars (2023 - $ 255.2 million of notional long positions). </context> | us-gaap:DerivativeNotionalAmount |
The fair value of these derivatives is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 0.5 million of notional long positions of exchange traded commodity option contracts (2023 - $ 0.4 million of notional long positions). The notional amounts for options are based on the fair value of the underlying commodities as if the options were exercised at the reporting date. | text | 0.5 | monetaryItemType | text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of these derivatives is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 0.5 million of notional long positions of exchange traded commodity option contracts (2023 - $ 0.4 million of notional long positions). The notional amounts for options are based on the fair value of the underlying commodities as if the options were exercised at the reporting date. </context> | us-gaap:DerivativeNotionalAmount |
The fair value of these derivatives is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 0.5 million of notional long positions of exchange traded commodity option contracts (2023 - $ 0.4 million of notional long positions). The notional amounts for options are based on the fair value of the underlying commodities as if the options were exercised at the reporting date. | text | 0.4 | monetaryItemType | text: <entity> 0.4 </entity> <entity type> monetaryItemType </entity type> <context> The fair value of these derivatives is determined using market-based prices from pricing vendors. At December 31, 2024, the Company had $ 0.5 million of notional long positions of exchange traded commodity option contracts (2023 - $ 0.4 million of notional long positions). The notional amounts for options are based on the fair value of the underlying commodities as if the options were exercised at the reporting date. </context> | us-gaap:DerivativeNotionalAmount |
At December 31, 2024, the Company’s banks have issued secured and unsecured letters of credit totaling $ 619.6 million in favor of certain ceding companies. In connection with the Company’s Top Layer joint venture, Renaissance Reinsurance has committed $ 37.5 million of collateral to support a letter of credit and is obligated to make a mandatory capital contribution of up to $ 50.0 million in the event that a loss reduces Top Layer’s capital and surplus below a specified level. | text | 619.6 | monetaryItemType | text: <entity> 619.6 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the Company’s banks have issued secured and unsecured letters of credit totaling $ 619.6 million in favor of certain ceding companies. In connection with the Company’s Top Layer joint venture, Renaissance Reinsurance has committed $ 37.5 million of collateral to support a letter of credit and is obligated to make a mandatory capital contribution of up to $ 50.0 million in the event that a loss reduces Top Layer’s capital and surplus below a specified level. </context> | us-gaap:LettersOfCreditOutstandingAmount |
At December 31, 2024, the Company’s banks have issued secured and unsecured letters of credit totaling $ 619.6 million in favor of certain ceding companies. In connection with the Company’s Top Layer joint venture, Renaissance Reinsurance has committed $ 37.5 million of collateral to support a letter of credit and is obligated to make a mandatory capital contribution of up to $ 50.0 million in the event that a loss reduces Top Layer’s capital and surplus below a specified level. | text | 37.5 | monetaryItemType | text: <entity> 37.5 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the Company’s banks have issued secured and unsecured letters of credit totaling $ 619.6 million in favor of certain ceding companies. In connection with the Company’s Top Layer joint venture, Renaissance Reinsurance has committed $ 37.5 million of collateral to support a letter of credit and is obligated to make a mandatory capital contribution of up to $ 50.0 million in the event that a loss reduces Top Layer’s capital and surplus below a specified level. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
At December 31, 2024, the Company’s banks have issued secured and unsecured letters of credit totaling $ 619.6 million in favor of certain ceding companies. In connection with the Company’s Top Layer joint venture, Renaissance Reinsurance has committed $ 37.5 million of collateral to support a letter of credit and is obligated to make a mandatory capital contribution of up to $ 50.0 million in the event that a loss reduces Top Layer’s capital and surplus below a specified level. | text | 50.0 | monetaryItemType | text: <entity> 50.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2024, the Company’s banks have issued secured and unsecured letters of credit totaling $ 619.6 million in favor of certain ceding companies. In connection with the Company’s Top Layer joint venture, Renaissance Reinsurance has committed $ 37.5 million of collateral to support a letter of credit and is obligated to make a mandatory capital contribution of up to $ 50.0 million in the event that a loss reduces Top Layer’s capital and surplus below a specified level. </context> | us-gaap:LossContingencyEstimateOfPossibleLoss |
The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 | text | 83.8 | monetaryItemType | text: <entity> 83.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 </context> | us-gaap:OperatingLeaseRightOfUseAsset |
The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 | text | 114.3 | monetaryItemType | text: <entity> 114.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 </context> | us-gaap:OperatingLeaseLiability |
The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 | text | 72.9 | monetaryItemType | text: <entity> 72.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 </context> | us-gaap:OperatingLeaseRightOfUseAsset |
The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 | text | 103.9 | monetaryItemType | text: <entity> 103.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 </context> | us-gaap:OperatingLeaseLiability |
The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 | text | 14.8 | monetaryItemType | text: <entity> 14.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s operating leases primarily relate to office space for its global underwriting platforms principally in Bermuda, Australia, Ireland, Singapore, Switzerland, the U.K. and the U.S. These leases expire at various dates through 2039 with a weighted average lease term of 5.9 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 83.8 million and a lease liability of $ 114.3 million, respectively, associated with the Company’s operating leases (2023 - $ 72.9 million and $ 103.9 million, respectively). During 2024, the Company recorded an operating lease expense of $ 14.8 million included in operational expenses (2023 </context> | us-gaap:OperatingLeaseExpense |
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). | text | 16.1 | monetaryItemType | text: <entity> 16.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). </context> | us-gaap:FinanceLeaseRightOfUseAsset |
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). | text | 21.0 | monetaryItemType | text: <entity> 21.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). </context> | us-gaap:FinanceLeaseLiability |
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). | text | 16.6 | monetaryItemType | text: <entity> 16.6 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). </context> | us-gaap:FinanceLeaseRightOfUseAsset |
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). | text | 21.5 | monetaryItemType | text: <entity> 21.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). </context> | us-gaap:FinanceLeaseLiability |
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). </context> | us-gaap:FinanceLeaseInterestExpense |
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). | text | 2.2 | monetaryItemType | text: <entity> 2.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). </context> | us-gaap:FinanceLeaseInterestExpense |
The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). | text | 0.5 | monetaryItemType | text: <entity> 0.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s financing leases primarily relate to office space in Bermuda with an initial lease term of 20 years, ending in 2028, and a bargain renewal option for an additional 30 years. Included in other assets and other liabilities at December 31, 2024 is a right-of-use asset of $ 16.1 million and a lease liability of $ 21.0 million, respectively, associated with the Company’s finance leases (2023 - $ 16.6 million and $ 21.5 million, respectively). During 2024, the Company recorded interest expense of $ 2.1 million associated with its finance leases (2023 - $ 2.2 million) included in interest expense and amortization of its finance leases right-to-use asset of $ 0.5 million included in operational expenses (2023 - $ 0.5 million). </context> | us-gaap:FinanceLeaseRightOfUseAssetAmortization |
Subsequent to December 31, 2024 and through the period ended February 7, 2025, the Company repurchased 928,880 common shares at an aggregate cost of $ 227.7 million and an average price of $ 245.10 per common share. | text | 928880 | sharesItemType | text: <entity> 928880 </entity> <entity type> sharesItemType </entity type> <context> Subsequent to December 31, 2024 and through the period ended February 7, 2025, the Company repurchased 928,880 common shares at an aggregate cost of $ 227.7 million and an average price of $ 245.10 per common share. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
Subsequent to December 31, 2024 and through the period ended February 7, 2025, the Company repurchased 928,880 common shares at an aggregate cost of $ 227.7 million and an average price of $ 245.10 per common share. | text | 227.7 | monetaryItemType | text: <entity> 227.7 </entity> <entity type> monetaryItemType </entity type> <context> Subsequent to December 31, 2024 and through the period ended February 7, 2025, the Company repurchased 928,880 common shares at an aggregate cost of $ 227.7 million and an average price of $ 245.10 per common share. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
Subsequent to December 31, 2024 and through the period ended February 7, 2025, the Company repurchased 928,880 common shares at an aggregate cost of $ 227.7 million and an average price of $ 245.10 per common share. | text | 245.10 | perShareItemType | text: <entity> 245.10 </entity> <entity type> perShareItemType </entity type> <context> Subsequent to December 31, 2024 and through the period ended February 7, 2025, the Company repurchased 928,880 common shares at an aggregate cost of $ 227.7 million and an average price of $ 245.10 per common share. </context> | us-gaap:TreasuryStockAcquiredAverageCostPerShare |
Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. | text | 69.7 | monetaryItemType | text: <entity> 69.7 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. </context> | us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance |
Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. | text | 26.9 | monetaryItemType | text: <entity> 26.9 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. </context> | us-gaap:MinorityInterestDecreaseFromRedemptions |
Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. | text | 69.7 | monetaryItemType | text: <entity> 69.7 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. </context> | us-gaap:ProceedsFromMinorityShareholders |
Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. | text | 24.3 | percentItemType | text: <entity> 24.3 </entity> <entity type> percentItemType </entity type> <context> Effective January 1, 2025, RenaissanceRe sold an aggregate of $ 69.7 million of its shares in DaVinci to third-party investors and purchased an aggregate of $ 26.9 million of shares from third-party investors. At December 31, 2024, $ 69.7 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in DaVinci subsequent to these transactions was 24.3 %. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. | text | 100.0 | monetaryItemType | text: <entity> 100.0 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. </context> | us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance |
Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. | text | 29.2 | monetaryItemType | text: <entity> 29.2 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. </context> | us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance |
Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. | text | 70.8 | monetaryItemType | text: <entity> 70.8 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. </context> | us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance |
Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. | text | 72.0 | monetaryItemType | text: <entity> 72.0 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. </context> | us-gaap:MinorityInterestDecreaseFromRedemptions |
Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. | text | 129.2 | monetaryItemType | text: <entity> 129.2 </entity> <entity type> monetaryItemType </entity type> <context> Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. </context> | us-gaap:ProceedsFromMinorityShareholders |
Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. | text | 28.7 | percentItemType | text: <entity> 28.7 </entity> <entity type> percentItemType </entity type> <context> Effective January 1, 2025, Fontana completed an equity capital raise of $ 100.0 million, comprised of $ 29.2 million from third-party investors and $ 70.8 million from RenaissanceRe. In addition, RenaissanceRe sold an aggregate of $ 100.0 million of its limited partner interest in Fontana to third-party investors and purchased an aggregate of $ 72.0 million of limited partner interest in Fontana from third-party investors. At December 31, 2024, $ 129.2 million, representing the net amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Fontana subsequent to these transactions was 28.7 %. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. | text | 107.9 | monetaryItemType | text: <entity> 107.9 </entity> <entity type> monetaryItemType </entity type> <context> Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. </context> | us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest |
Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. | text | 50.1 | monetaryItemType | text: <entity> 50.1 </entity> <entity type> monetaryItemType </entity type> <context> Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. </context> | us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest |
Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. | text | 16.5 | monetaryItemType | text: <entity> 16.5 </entity> <entity type> monetaryItemType </entity type> <context> Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. </context> | us-gaap:MinorityInterestDecreaseFromRedemptions |
Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. | text | 15.2 | monetaryItemType | text: <entity> 15.2 </entity> <entity type> monetaryItemType </entity type> <context> Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. </context> | us-gaap:PaymentsOfDividends |
Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. | text | 39.0 | monetaryItemType | text: <entity> 39.0 </entity> <entity type> monetaryItemType </entity type> <context> Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. </context> | us-gaap:ProceedsFromMinorityShareholders |
Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. | text | 17.7 | percentItemType | text: <entity> 17.7 </entity> <entity type> percentItemType </entity type> <context> Effective in January and February 2025, Medici issued an aggregate of $ 107.9 million of non-voting preference shares to investors, including $ 50.1 million to the Company, and redeemed an aggregate of $ 16.5 million of non-voting preference shares to investors, including $ Nil to the Company. In January 2025, Medici declared a dividend of $ 15.2 million, all of which is payable to third-party investors. At December 31, 2024, $ 39.0 million, representing the amount received from investors other than the Company prior to January 1, 2025, is included in other liabilities on the Company’s consolidated balance sheet, and also included in cash flows provided by financing activities on the Company’s consolidated statements of cash flows for the year ended December 31, 2024. The Company’s noncontrolling economic ownership in Medici subsequent to these transactions was 17.7 % effective February 1, 2025. </context> | us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners |
commencing in January 2025, have led to a range of publicly available industry insured loss estimates. The Company expects its pre-tax net negative impact to be approximately 1.5 % of the California wildfires’ aggregate industry insured loss. Based on a $ 50 billion aggregate industry insured loss, the Company estimates a pre-tax net negative impact on net income (loss) available (attributable) to common shareholders of approximately $ 750 million in the first quarter of 2025. The Company expects the wildfires will primarily impact its Property segment and, to a lesser extent, the Casualty and Specialty segment. | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> commencing in January 2025, have led to a range of publicly available industry insured loss estimates. The Company expects its pre-tax net negative impact to be approximately 1.5 % of the California wildfires’ aggregate industry insured loss. Based on a $ 50 billion aggregate industry insured loss, the Company estimates a pre-tax net negative impact on net income (loss) available (attributable) to common shareholders of approximately $ 750 million in the first quarter of 2025. The Company expects the wildfires will primarily impact its Property segment and, to a lesser extent, the Casualty and Specialty segment. </context> | us-gaap:LossContingencyEstimateOfPossibleLoss |
On an annual basis and at interim periods when circumstances require, the Company tests the recoverability of its goodwill. The analysis is conducted as of October 1 each year. The Company has two reporting units and compares the carrying value of its reporting units to the fair value. If the carrying value of the reporting unit is greater than its fair value, the Company recognizes an impairment charge for the amount equal to that excess. | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> On an annual basis and at interim periods when circumstances require, the Company tests the recoverability of its goodwill. The analysis is conducted as of October 1 each year. The Company has two reporting units and compares the carrying value of its reporting units to the fair value. If the carrying value of the reporting unit is greater than its fair value, the Company recognizes an impairment charge for the amount equal to that excess. </context> | us-gaap:NumberOfReportingUnits |
The Company is principally engaged in the business of renting equipment. Ancillary to the Company’s principal equipment rental business, the Company also sells used rental equipment, new equipment and parts and supplies and offers certain services to support its customers. The Company operates in North America with revenue from the United States representing 92.9 %, 92.0 % and 91.2 % of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 92.9 | percentItemType | text: <entity> 92.9 </entity> <entity type> percentItemType </entity type> <context> The Company is principally engaged in the business of renting equipment. Ancillary to the Company’s principal equipment rental business, the Company also sells used rental equipment, new equipment and parts and supplies and offers certain services to support its customers. The Company operates in North America with revenue from the United States representing 92.9 %, 92.0 % and 91.2 % of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
The Company is principally engaged in the business of renting equipment. Ancillary to the Company’s principal equipment rental business, the Company also sells used rental equipment, new equipment and parts and supplies and offers certain services to support its customers. The Company operates in North America with revenue from the United States representing 92.9 %, 92.0 % and 91.2 % of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 92.0 | percentItemType | text: <entity> 92.0 </entity> <entity type> percentItemType </entity type> <context> The Company is principally engaged in the business of renting equipment. Ancillary to the Company’s principal equipment rental business, the Company also sells used rental equipment, new equipment and parts and supplies and offers certain services to support its customers. The Company operates in North America with revenue from the United States representing 92.9 %, 92.0 % and 91.2 % of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
The Company is principally engaged in the business of renting equipment. Ancillary to the Company’s principal equipment rental business, the Company also sells used rental equipment, new equipment and parts and supplies and offers certain services to support its customers. The Company operates in North America with revenue from the United States representing 92.9 %, 92.0 % and 91.2 % of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 91.2 | percentItemType | text: <entity> 91.2 </entity> <entity type> percentItemType </entity type> <context> The Company is principally engaged in the business of renting equipment. Ancillary to the Company’s principal equipment rental business, the Company also sells used rental equipment, new equipment and parts and supplies and offers certain services to support its customers. The Company operates in North America with revenue from the United States representing 92.9 %, 92.0 % and 91.2 % of total revenue for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ConcentrationRiskPercentage1 |
Under Topic 606, the accounts receivable balance, prior to allowances for credit losses, for the sale of rental equipment, new equipment, parts and supplies, was approximately $ 17 million and $ 11 million as of December 31, 2024 and 2023, respectively. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> Under Topic 606, the accounts receivable balance, prior to allowances for credit losses, for the sale of rental equipment, new equipment, parts and supplies, was approximately $ 17 million and $ 11 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerAssetNetCurrent |
Under Topic 606, the accounts receivable balance, prior to allowances for credit losses, for the sale of rental equipment, new equipment, parts and supplies, was approximately $ 17 million and $ 11 million as of December 31, 2024 and 2023, respectively. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> Under Topic 606, the accounts receivable balance, prior to allowances for credit losses, for the sale of rental equipment, new equipment, parts and supplies, was approximately $ 17 million and $ 11 million as of December 31, 2024 and 2023, respectively. </context> | us-gaap:ContractWithCustomerAssetNetCurrent |
Depreciation expense for the years ended December 31, 2024, 2023 and 2022 was $ 82 million, $ 71 million and $ 64 million, respectively, and is included in "Non-rental depreciation and amortization" in the Company's consolidated statements of operations. | text | 82 | monetaryItemType | text: <entity> 82 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024, 2023 and 2022 was $ 82 million, $ 71 million and $ 64 million, respectively, and is included in "Non-rental depreciation and amortization" in the Company's consolidated statements of operations. </context> | us-gaap:DepreciationNonproduction |
Depreciation expense for the years ended December 31, 2024, 2023 and 2022 was $ 82 million, $ 71 million and $ 64 million, respectively, and is included in "Non-rental depreciation and amortization" in the Company's consolidated statements of operations. | text | 71 | monetaryItemType | text: <entity> 71 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024, 2023 and 2022 was $ 82 million, $ 71 million and $ 64 million, respectively, and is included in "Non-rental depreciation and amortization" in the Company's consolidated statements of operations. </context> | us-gaap:DepreciationNonproduction |
Depreciation expense for the years ended December 31, 2024, 2023 and 2022 was $ 82 million, $ 71 million and $ 64 million, respectively, and is included in "Non-rental depreciation and amortization" in the Company's consolidated statements of operations. | text | 64 | monetaryItemType | text: <entity> 64 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation expense for the years ended December 31, 2024, 2023 and 2022 was $ 82 million, $ 71 million and $ 64 million, respectively, and is included in "Non-rental depreciation and amortization" in the Company's consolidated statements of operations. </context> | us-gaap:DepreciationNonproduction |
On July 16, 2024, the Company completed the acquisition of substantially all of the assets of Otay Mesa Sales ("Otay"). Otay was a full-service general equipment rental company comprised of approximately 135 employees and 4 locations serving construction and industrial customers throughout the metropolitan areas of San Diego, California and Phoenix and Yuma, Arizona. The aggregate consideration for the acquisition was approximately $ 273 million. The acquisition and related fees and expenses were funded through available cash and drawings on the senior secured asset-based revolving credit facility. | text | 273 | monetaryItemType | text: <entity> 273 </entity> <entity type> monetaryItemType </entity type> <context> On July 16, 2024, the Company completed the acquisition of substantially all of the assets of Otay Mesa Sales ("Otay"). Otay was a full-service general equipment rental company comprised of approximately 135 employees and 4 locations serving construction and industrial customers throughout the metropolitan areas of San Diego, California and Phoenix and Yuma, Arizona. The aggregate consideration for the acquisition was approximately $ 273 million. The acquisition and related fees and expenses were funded through available cash and drawings on the senior secured asset-based revolving credit facility. </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
The assets and liabilities for Otay were recorded as of July 16, 2024 and the results of operations have been included in the Company's consolidated results of operations since that date. Total revenue and income before taxes for Otay included in the consolidated statement of operations since the acquisition date are $ 35 million and $ 6 million, respectively. | text | 35 | monetaryItemType | text: <entity> 35 </entity> <entity type> monetaryItemType </entity type> <context> The assets and liabilities for Otay were recorded as of July 16, 2024 and the results of operations have been included in the Company's consolidated results of operations since that date. Total revenue and income before taxes for Otay included in the consolidated statement of operations since the acquisition date are $ 35 million and $ 6 million, respectively. </context> | us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual |
The assets and liabilities for Otay were recorded as of July 16, 2024 and the results of operations have been included in the Company's consolidated results of operations since that date. Total revenue and income before taxes for Otay included in the consolidated statement of operations since the acquisition date are $ 35 million and $ 6 million, respectively. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> The assets and liabilities for Otay were recorded as of July 16, 2024 and the results of operations have been included in the Company's consolidated results of operations since that date. Total revenue and income before taxes for Otay included in the consolidated statement of operations since the acquisition date are $ 35 million and $ 6 million, respectively. </context> | us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual |
In addition to the acquisition of Otay disclosed above, during the year ended December 31, 2024, the Company acquired eight companies with a total of 24 branches. During the year ended December 31, 2023, the Company acquired 12 companies totaling 21 branches. | text | eight | integerItemType | text: <entity> eight </entity> <entity type> integerItemType </entity type> <context> In addition to the acquisition of Otay disclosed above, during the year ended December 31, 2024, the Company acquired eight companies with a total of 24 branches. During the year ended December 31, 2023, the Company acquired 12 companies totaling 21 branches. </context> | us-gaap:NumberOfBusinessesAcquired |
In addition to the acquisition of Otay disclosed above, during the year ended December 31, 2024, the Company acquired eight companies with a total of 24 branches. During the year ended December 31, 2023, the Company acquired 12 companies totaling 21 branches. | text | 12 | integerItemType | text: <entity> 12 </entity> <entity type> integerItemType </entity type> <context> In addition to the acquisition of Otay disclosed above, during the year ended December 31, 2024, the Company acquired eight companies with a total of 24 branches. During the year ended December 31, 2023, the Company acquired 12 companies totaling 21 branches. </context> | us-gaap:NumberOfBusinessesAcquired |
The Company performed its annual goodwill impairment test as of October 1 and determined that no impairment existed at such date. Subsequent to the annual impairment test, it was determined that goodwill classified as assets held for sale was fully impaired, see Note 8, "Assets Held for Sale" for further discussion. There was no impairment during the year ended December 31, 2023. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Company performed its annual goodwill impairment test as of October 1 and determined that no impairment existed at such date. Subsequent to the annual impairment test, it was determined that goodwill classified as assets held for sale was fully impaired, see Note 8, "Assets Held for Sale" for further discussion. There was no impairment during the year ended December 31, 2023. </context> | us-gaap:GoodwillImpairmentLoss |
The Company performed its annual impairment test of indefinite-lived intangible assets as of October 1 and assessed finite-lived intangible assets for impairment triggers and determined that no impairment existed at such date. Subsequent to the annual impairment test, it was determined that certain finite-lived intangible assets classified as assets held for sale were impaired, see Note 8, "Assets Held for Sale" for further discussion. There was no impairment during the year ended December 31, 2023. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Company performed its annual impairment test of indefinite-lived intangible assets as of October 1 and assessed finite-lived intangible assets for impairment triggers and determined that no impairment existed at such date. Subsequent to the annual impairment test, it was determined that certain finite-lived intangible assets classified as assets held for sale were impaired, see Note 8, "Assets Held for Sale" for further discussion. There was no impairment during the year ended December 31, 2023. </context> | us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill |
(a) Includes capitalized costs of $ 14 million yet to be placed into service. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> (a) Includes capitalized costs of $ 14 million yet to be placed into service. </context> | us-gaap:FiniteLivedIntangibleAssetsNet |
The Company assesses the fair value, less estimated costs to sell, each reporting period it remains classified as held for sale. During the fourth quarter of 2024, there was indication that the carrying value of Cinelease was greater than the fair value, less estimated costs to sell, based on slower than anticipated return of business subsequent to settlement of actual and potential labor strikes, therefore an impairment analysis was performed. The fair value was estimated using a market approach based on offers received through a competitive bid process, exclusive of potential earnouts for future performance. Accordingly, the Company recorded a loss on assets held for sale of approximately $ 194 million. | text | 194 | monetaryItemType | text: <entity> 194 </entity> <entity type> monetaryItemType </entity type> <context> The Company assesses the fair value, less estimated costs to sell, each reporting period it remains classified as held for sale. During the fourth quarter of 2024, there was indication that the carrying value of Cinelease was greater than the fair value, less estimated costs to sell, based on slower than anticipated return of business subsequent to settlement of actual and potential labor strikes, therefore an impairment analysis was performed. The fair value was estimated using a market approach based on offers received through a competitive bid process, exclusive of potential earnouts for future performance. Accordingly, the Company recorded a loss on assets held for sale of approximately $ 194 million. </context> | us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown |
(a) Finance lease right-of-use assets are recorded net of accumulated amortization of $ 52 million and $ 37 million for the years ended December 31, 2024 and 2023, respectively. | text | 52 | monetaryItemType | text: <entity> 52 </entity> <entity type> monetaryItemType </entity type> <context> (a) Finance lease right-of-use assets are recorded net of accumulated amortization of $ 52 million and $ 37 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization |
(a) Finance lease right-of-use assets are recorded net of accumulated amortization of $ 52 million and $ 37 million for the years ended December 31, 2024 and 2023, respectively. | text | 37 | monetaryItemType | text: <entity> 37 </entity> <entity type> monetaryItemType </entity type> <context> (a) Finance lease right-of-use assets are recorded net of accumulated amortization of $ 52 million and $ 37 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization |
(a) Unamortized debt issuance costs totaling $ 6 million and $ 8 million related to the ABL Credit Facility and AR Facility (as each is defined below) as of December 31, 2024 and 2023, respectively, are included in "Other long-term assets" in the consolidated balance sheets. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> (a) Unamortized debt issuance costs totaling $ 6 million and $ 8 million related to the ABL Credit Facility and AR Facility (as each is defined below) as of December 31, 2024 and 2023, respectively, are included in "Other long-term assets" in the consolidated balance sheets. </context> | us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet |
(a) Unamortized debt issuance costs totaling $ 6 million and $ 8 million related to the ABL Credit Facility and AR Facility (as each is defined below) as of December 31, 2024 and 2023, respectively, are included in "Other long-term assets" in the consolidated balance sheets. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> (a) Unamortized debt issuance costs totaling $ 6 million and $ 8 million related to the ABL Credit Facility and AR Facility (as each is defined below) as of December 31, 2024 and 2023, respectively, are included in "Other long-term assets" in the consolidated balance sheets. </context> | us-gaap:DebtIssuanceCostsLineOfCreditArrangementsNet |
On July 9, 2019, the Company issued $ 1.2 billion aggregate principal amount of its 5.50 % Senior Notes due 2027 (the “2027 Notes”). Interest on the 2027 Notes accrues at the rate of 5.50 % per annum and is payable semi-annually in arrears on January 15 and July 15. The 2027 Notes will mature on July 15, 2027. | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> On July 9, 2019, the Company issued $ 1.2 billion aggregate principal amount of its 5.50 % Senior Notes due 2027 (the “2027 Notes”). Interest on the 2027 Notes accrues at the rate of 5.50 % per annum and is payable semi-annually in arrears on January 15 and July 15. The 2027 Notes will mature on July 15, 2027. </context> | us-gaap:DebtInstrumentFaceAmount |
On July 9, 2019, the Company issued $ 1.2 billion aggregate principal amount of its 5.50 % Senior Notes due 2027 (the “2027 Notes”). Interest on the 2027 Notes accrues at the rate of 5.50 % per annum and is payable semi-annually in arrears on January 15 and July 15. The 2027 Notes will mature on July 15, 2027. | text | 5.50 | percentItemType | text: <entity> 5.50 </entity> <entity type> percentItemType </entity type> <context> On July 9, 2019, the Company issued $ 1.2 billion aggregate principal amount of its 5.50 % Senior Notes due 2027 (the “2027 Notes”). Interest on the 2027 Notes accrues at the rate of 5.50 % per annum and is payable semi-annually in arrears on January 15 and July 15. The 2027 Notes will mature on July 15, 2027. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The Company may redeem the 2027 Notes, in whole or in part, at any time (i) on or after July 15, 2024 and prior to July 15, 2025, at a price equal to 100.917 % of the principal amount of the 2027 Notes and (ii) on or after July 15, 2025, at a price equal to 100.000 % of the principal amount of the 2027 Notes, in each case, plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date. | text | 100.917 | percentItemType | text: <entity> 100.917 </entity> <entity type> percentItemType </entity type> <context> The Company may redeem the 2027 Notes, in whole or in part, at any time (i) on or after July 15, 2024 and prior to July 15, 2025, at a price equal to 100.917 % of the principal amount of the 2027 Notes and (ii) on or after July 15, 2025, at a price equal to 100.000 % of the principal amount of the 2027 Notes, in each case, plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Company may redeem the 2027 Notes, in whole or in part, at any time (i) on or after July 15, 2024 and prior to July 15, 2025, at a price equal to 100.917 % of the principal amount of the 2027 Notes and (ii) on or after July 15, 2025, at a price equal to 100.000 % of the principal amount of the 2027 Notes, in each case, plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date. | text | 100.000 | percentItemType | text: <entity> 100.000 </entity> <entity type> percentItemType </entity type> <context> The Company may redeem the 2027 Notes, in whole or in part, at any time (i) on or after July 15, 2024 and prior to July 15, 2025, at a price equal to 100.917 % of the principal amount of the 2027 Notes and (ii) on or after July 15, 2025, at a price equal to 100.000 % of the principal amount of the 2027 Notes, in each case, plus accrued and unpaid interest, if any, to, but not including, the applicable redemption date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The indenture governing the 2027 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on liens, indebtedness, mergers, consolidations and acquisitions, sales, transfers and other dispositions of assets, loans and other investments, dividends and other distributions, stock repurchases and redemptions and other restricted payments, restrictions affecting subsidiaries, transactions with affiliates and designations of unrestricted subsidiaries. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2027 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any to (but excluding) the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2027 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. | text | 101 | percentItemType | text: <entity> 101 </entity> <entity type> percentItemType </entity type> <context> The indenture governing the 2027 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on liens, indebtedness, mergers, consolidations and acquisitions, sales, transfers and other dispositions of assets, loans and other investments, dividends and other distributions, stock repurchases and redemptions and other restricted payments, restrictions affecting subsidiaries, transactions with affiliates and designations of unrestricted subsidiaries. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2027 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any to (but excluding) the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2027 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The indenture governing the 2027 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on liens, indebtedness, mergers, consolidations and acquisitions, sales, transfers and other dispositions of assets, loans and other investments, dividends and other distributions, stock repurchases and redemptions and other restricted payments, restrictions affecting subsidiaries, transactions with affiliates and designations of unrestricted subsidiaries. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2027 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any to (but excluding) the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2027 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The indenture governing the 2027 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on liens, indebtedness, mergers, consolidations and acquisitions, sales, transfers and other dispositions of assets, loans and other investments, dividends and other distributions, stock repurchases and redemptions and other restricted payments, restrictions affecting subsidiaries, transactions with affiliates and designations of unrestricted subsidiaries. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2027 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any to (but excluding) the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2027 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
On June 7, 2024, the Company issued $ 800 million aggregate principal amount of its 6.625 % Senior Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes, the "Notes"). The net proceeds were used to repay a portion of the indebtedness outstanding under the ABL Credit Facility and to pay related fees and expenses. Interest on the 2029 Notes accrues at the rate of 6.625 % per annum and will be payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2024. The 2029 Notes will mature on June 15, 2029. | text | 800 | monetaryItemType | text: <entity> 800 </entity> <entity type> monetaryItemType </entity type> <context> On June 7, 2024, the Company issued $ 800 million aggregate principal amount of its 6.625 % Senior Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes, the "Notes"). The net proceeds were used to repay a portion of the indebtedness outstanding under the ABL Credit Facility and to pay related fees and expenses. Interest on the 2029 Notes accrues at the rate of 6.625 % per annum and will be payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2024. The 2029 Notes will mature on June 15, 2029. </context> | us-gaap:DebtInstrumentFaceAmount |
On June 7, 2024, the Company issued $ 800 million aggregate principal amount of its 6.625 % Senior Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes, the "Notes"). The net proceeds were used to repay a portion of the indebtedness outstanding under the ABL Credit Facility and to pay related fees and expenses. Interest on the 2029 Notes accrues at the rate of 6.625 % per annum and will be payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2024. The 2029 Notes will mature on June 15, 2029. | text | 6.625 | percentItemType | text: <entity> 6.625 </entity> <entity type> percentItemType </entity type> <context> On June 7, 2024, the Company issued $ 800 million aggregate principal amount of its 6.625 % Senior Notes due 2029 (the "2029 Notes" and, together with the 2027 Notes, the "Notes"). The net proceeds were used to repay a portion of the indebtedness outstanding under the ABL Credit Facility and to pay related fees and expenses. Interest on the 2029 Notes accrues at the rate of 6.625 % per annum and will be payable semi-annually in arrears on June 15 and December 15 of each year, commencing on December 15, 2024. The 2029 Notes will mature on June 15, 2029. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on | text | 103.313 | percentItemType | text: <entity> 103.313 </entity> <entity type> percentItemType </entity type> <context> The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on | text | 101.656 | percentItemType | text: <entity> 101.656 </entity> <entity type> percentItemType </entity type> <context> The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on | text | 100.000 | percentItemType | text: <entity> 100.000 </entity> <entity type> percentItemType </entity type> <context> The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time prior to June 15, 2026, at a price equal to 100 % of the aggregate principal amount of the 2029 Notes, plus the applicable make-whole premium and accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem the 2029 Notes, in whole or in part, at any time (i) on or after June 15, 2026 and prior to June 15, 2027, at a price equal to 103.313 % of the principal amount of the 2029 Notes, (ii) on or after June 15, 2027 and prior to June 15, 2028, at a price equal to 101.656 % of the principal amount of the 2029 Notes and (iii) on or after June 15, 2028, at a price equal to 100.000 % of the principal amount of the 2029 Notes, in each case, plus accrued and unpaid interest, if any, to, but excluding, the applicable redemption date. In addition, at any time on </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
or prior to June 15, 2026, the Company may, at its option, redeem up to 40 % of the aggregate principal amount of the 2029 Notes with the net cash proceeds of one or more equity offerings at a redemption price equal to 106.625 % of the principal amount of the 2029 Notes, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. | text | 40 | percentItemType | text: <entity> 40 </entity> <entity type> percentItemType </entity type> <context> or prior to June 15, 2026, the Company may, at its option, redeem up to 40 % of the aggregate principal amount of the 2029 Notes with the net cash proceeds of one or more equity offerings at a redemption price equal to 106.625 % of the principal amount of the 2029 Notes, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed |
or prior to June 15, 2026, the Company may, at its option, redeem up to 40 % of the aggregate principal amount of the 2029 Notes with the net cash proceeds of one or more equity offerings at a redemption price equal to 106.625 % of the principal amount of the 2029 Notes, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. | text | 106.625 | percentItemType | text: <entity> 106.625 </entity> <entity type> percentItemType </entity type> <context> or prior to June 15, 2026, the Company may, at its option, redeem up to 40 % of the aggregate principal amount of the 2029 Notes with the net cash proceeds of one or more equity offerings at a redemption price equal to 106.625 % of the principal amount of the 2029 Notes, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The indenture governing the 2029 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on: indebtedness; restricted payments; liens; dispositions of proceeds from asset sales; transactions with affiliates; dividends and other payment restrictions affecting restricted subsidiaries; designations of unrestricted subsidiaries; and mergers, consolidations and sale of assets. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2029 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2029 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. | text | 101 | percentItemType | text: <entity> 101 </entity> <entity type> percentItemType </entity type> <context> The indenture governing the 2029 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on: indebtedness; restricted payments; liens; dispositions of proceeds from asset sales; transactions with affiliates; dividends and other payment restrictions affecting restricted subsidiaries; designations of unrestricted subsidiaries; and mergers, consolidations and sale of assets. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2029 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2029 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The indenture governing the 2029 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on: indebtedness; restricted payments; liens; dispositions of proceeds from asset sales; transactions with affiliates; dividends and other payment restrictions affecting restricted subsidiaries; designations of unrestricted subsidiaries; and mergers, consolidations and sale of assets. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2029 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2029 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The indenture governing the 2029 Notes contains certain covenants applicable to the Company and its restricted subsidiaries, including limitations on: indebtedness; restricted payments; liens; dispositions of proceeds from asset sales; transactions with affiliates; dividends and other payment restrictions affecting restricted subsidiaries; designations of unrestricted subsidiaries; and mergers, consolidations and sale of assets. Upon the occurrence of certain events constituting a change of control triggering event, the Company is required to make an offer to repurchase all of the 2029 Notes (unless otherwise redeemed) at a purchase price equal to 101 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. If the Company sells assets under certain circumstances, it must use the proceeds to make an offer to purchase the 2029 Notes at a price equal to 100 % of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
On July 31, 2019, Herc Holdings, Herc and certain other subsidiaries of Herc Holdings entered into a credit agreement with respect to a senior secured asset-based revolving credit facility, which was amended and extended on July 5, 2022. The aggregate amount of the revolving credit commitments is $ 3.5 billion (subject to availability under a borrowing base). Up to $ 250 million of the revolving loan facility is available for the issuance of letters of credit, subject to certain conditions including issuing lender participation. Subject to the satisfaction of certain conditions and limitations, the ABL Credit Facility allows for the addition of incremental revolving commitments and/or incremental term loans. | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> On July 31, 2019, Herc Holdings, Herc and certain other subsidiaries of Herc Holdings entered into a credit agreement with respect to a senior secured asset-based revolving credit facility, which was amended and extended on July 5, 2022. The aggregate amount of the revolving credit commitments is $ 3.5 billion (subject to availability under a borrowing base). Up to $ 250 million of the revolving loan facility is available for the issuance of letters of credit, subject to certain conditions including issuing lender participation. Subject to the satisfaction of certain conditions and limitations, the ABL Credit Facility allows for the addition of incremental revolving commitments and/or incremental term loans. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On July 31, 2019, Herc Holdings, Herc and certain other subsidiaries of Herc Holdings entered into a credit agreement with respect to a senior secured asset-based revolving credit facility, which was amended and extended on July 5, 2022. The aggregate amount of the revolving credit commitments is $ 3.5 billion (subject to availability under a borrowing base). Up to $ 250 million of the revolving loan facility is available for the issuance of letters of credit, subject to certain conditions including issuing lender participation. Subject to the satisfaction of certain conditions and limitations, the ABL Credit Facility allows for the addition of incremental revolving commitments and/or incremental term loans. | text | 250 | monetaryItemType | text: <entity> 250 </entity> <entity type> monetaryItemType </entity type> <context> On July 31, 2019, Herc Holdings, Herc and certain other subsidiaries of Herc Holdings entered into a credit agreement with respect to a senior secured asset-based revolving credit facility, which was amended and extended on July 5, 2022. The aggregate amount of the revolving credit commitments is $ 3.5 billion (subject to availability under a borrowing base). Up to $ 250 million of the revolving loan facility is available for the issuance of letters of credit, subject to certain conditions including issuing lender participation. Subject to the satisfaction of certain conditions and limitations, the ABL Credit Facility allows for the addition of incremental revolving commitments and/or incremental term loans. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
The interest rates applicable to any loans under the ABL Credit Facility are based, at the option of the borrowers, on (i) a floating rate based on Term SOFR (for loans denominated in U.S. dollars) or CORRA (for loans denominated in Canadian dollars) plus an initial margin of 1.375 % and a SOFR adjustment of 0.10 % per annum or (ii) a base rate plus an initial margin of 0.50 %, in each case, where margin is adjusted under the ABL Credit Facility based on the quarterly average excess availability under the ABL Credit Facility. | text | 1.375 | percentItemType | text: <entity> 1.375 </entity> <entity type> percentItemType </entity type> <context> The interest rates applicable to any loans under the ABL Credit Facility are based, at the option of the borrowers, on (i) a floating rate based on Term SOFR (for loans denominated in U.S. dollars) or CORRA (for loans denominated in Canadian dollars) plus an initial margin of 1.375 % and a SOFR adjustment of 0.10 % per annum or (ii) a base rate plus an initial margin of 0.50 %, in each case, where margin is adjusted under the ABL Credit Facility based on the quarterly average excess availability under the ABL Credit Facility. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.